Unknown

Dataset Information

Humoral waning kinetics against SARS-CoV-2 is dictated by disease severity and vaccine platform.


ABSTRACT: SARS-CoV-2 vaccine-acquired immunity provides robust cross-variant recognition, while infection-acquired immunity can be heterogenous, with disease severity often modulating post-recovery responses. We assessed antibody waning dynamics between infection- and vaccination-acquired immunity across variants of concern (VOC). mRNA vaccination induced potent, cross-VOC Spike recognition and functional responses, but waned more rapidly for Omicron Spike. Hospitalized individuals developed more durable functional responses with lower peaks compared to mRNA vaccination, while outpatients exhibited slower decay than inactivated vaccine recipients. Humoral decay for the receptor binding domain tracked with neutralizing antibody titers, while S2-directed responses tracked with antibody-dependent myelo

SUBMITTER: Tong X 

PROVIDER: S-EPMC11527045 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature